Houston Methodist. Leading Medicine.
Houston Methodist. Leading Medicine

Dan Gombos, M.D., F.A.C.S.

Daniel S. Gombos, M.D., F.A.C.S.

Daniel S. Gombos, M.D., F.A.C.S.

Daniel S. Gombos, M.D., F.A.C.S.

Associate Member
The Methodist Hospital Research Institute
Associate Professor
Department of Head and Neck Surgery
Section of Ophthalmology
The University of Texas M.D. Anderson Cancer Center

Phone: 713-794-5588
Fax: 713-794-4662
Email: dgombos@mdanderson.org


B.A.   Northwestern University, Evanston, IL (Chemistry)
M.D.   Stanford University School of Medicine, Stanford, CA

Postdoctoral Training

Transitional Internship, Mercy Hospital and Medical Center, San Diego, CA
Ophthalmology Residency, Scheie Eye Institute, Department of Ophthalmology, University of Pennsylvania, Philadelphia, PA
Ocular Oncology Fellowship, Department of Ophthalmology, University of California, San Francisco, CA
Ocular Oncology Fellowship, Moorfields Eye Hospital and St. Bartholomew's Hospital, London, UK



After completing his postdoctoral training in London, UK, Dr. Gombos returned to The University of
Texas M.D. Anderson Cancer Center (MDACC) in Houston, Texas as an Assistant Professor in 2001. He also joined the faculty at The University of Texas Medical Branch in Galveston, Texas in 2005 as a Clinical Assistant Professor of Ophthalmology and Visual Sciences. Dr. Gombos became an Associate Professor at MDACC in 2007, and a Clinical Associate Professor at The University of Texas Medical Branch in 2008. At MDACC, he is currently developing a comprehensive program for the management of patients with intra and periocular tumors. The program will also include special services for children with intraocular retinoblastoma. Dr. Gombos was also a founding physician in the Retinoblastoma Center of Houston, a collaborative effort between The Methodist Hospital, Baylor College of Medicine, Texas Children's Hospital, and MDACC that provides a comprehensive treatment program for retinoblastoma patients and conducts groundbreaking research to improve diagnostic methods and treatment and public awareness campaigns to promote early detection.

Description of Research

Dr. Gombos' research involves clinical trials that use proton beam radiation therapy or gene transfer therapy for pediatric refractory retinoblastoma.  

Major Areas of Research

Retinoblastoma, intraocular tumors, radiation therapy, gene transfer


Rodney AJ, Gombos DS, Fuller GN, Pagliaro LC, Tannir NM. Choroidal and conjunctival metastases from renal cell carcinoma. Am J Clin Oncol. 2009 Aug;32(4):448-9.

Rodney AJ, Gombos DS, Pagliaro LC, Tannir NM. Ischemic optic neuropathy associated with low dose interferon alfa: report of two cases. Am J Clin Oncol. 2009 Feb;32(1):86-7.

Rich TA, Jonasch E, Matin S, Waguespack SG, Gombos DS, Santarpia L, Stolle C, Jimenez C. A novel von Hippel-Lindau point mutation presents as apparently sporadic pheochromocytoma. Cancer Invest. 2008 Jul;26(6):642-6.

Gombos DS, Chevez-Barrios AP. Current treatment and management of retinoblastoma. Curr Oncol Rep. 2007 Nov;9(6):453-8.

Gombos DS, Hungerford J, Abramson DH, Kingston J, Chantada G, Dunkel IJ, Antoneli CB, Greenwald M, Haik BG, Leal CA, Medina-Sanson A, Schefler AC, Veerakul G, Wieland R, Bornfeld N, Wilson MW, Yu CB. Secondary acute myelogenous leukemia in patients with retinoblastoma: is chemotherapy a factor? Ophthalmology. 2007 Jul;114(7):1378-83.


Dr. Gombos' Physician Profile at MD Anderson Cancer Center